期刊論文| 1. | 劉孔中(20120600)。專利庫--經濟取向分析下之法制比較與調和。智慧財產評論，10(1)，23-24。 延伸查詢 |
| 2. | Hovenkamp, Herbert J.、Janis, Mark D.、Lemley, Mark A.(2003)。Anticompetitive Settlement of Intellectual Property Disputes。Minn. L. Rev.，87，1719-1766。  |
| 3. | 陳昭華、鍾鏡湖、張乃文、鄭耀誠(20080600)。學名藥試驗免責規範之探討。輔仁法學，35，225-273。 延伸查詢 |
| 4. | Galvan, Alex(2014)。A Second Opinion on Pharmaceutical Reverse Payment Settlements: Why Actavis Missed the Mark。Ga. St. U. L. Rev.，30，561+564。 |
| 5. | Hogges-Thomas, Alicia I.(2013)。Winning the War on Drug Prices: Analyzing Reverse Payment Settlements Through the Lens of Trinko。Hastings L.J，64，1421+1427。 |
| 6. | Brown, Alyssa L.(2012)。Modest Proposals for a Complex Problem: Patent Misuse and Incremental Changes to the Hatch-Waxman Act as Solutions to the Problem of Reverse。Payment Settlements，41，583+596。 |
| 7. | Gavil, Andrew I.(2012)。Moving Beyond Caricature and Characterization: The Modern Rule of Reason in Practice。Southern California Law Review，85，733-782。 |
| 8. | Hemphill, C. Scott(2009)。An Aggregate Approach to Antitrust: Using New Data and Rulemaking to Preserve Drug Competition。COLUM. L. Rev.，109，629+641。 |
| 9. | Hemphill, C. Scott(2006)。Paying for Delay: Pharmaceutical Patent Settlement as a Regulatory Design Problem。New York University Law Review，81(5)。 |
| 10. | Hittinger, Carl W.、Esposito, Leslie C.(2013)。Inre: K-Dur Antitrust Litigation: The Third Circuit's Controversial Pay-for-Delay Antitrust Decision Splits with Other Circuit Courts。VlLL. L. Rev.，58，103-118。 |
| 11. | Sandoval, Catherine J. K.(2010)。Pharmaceutical Reverse Payment Settlements: Presumptions, Procedural Burdens, and Covenants Not to Sue Generic Drug Manufacturers。Santa Clara COMPUTER and High Tech. L.J.，26，141+142。 |
| 12. | Christopher M. Holman,(2006)。Do Reverse Payment Settlements Violate the Antitrust Laws。SANTA Clara High Tech. L.J，23，489+502-503。 |
| 13. | Daniel A. Crane,(2004)。Ease Over Accuracy in Assessing Patent Settlements: A Response to Hovenkamp, Janis and Lemley。Minn. L. Rev.，87，698-709。 |
| 14. | Crane, Daniel A.(2002)。Exit Payments in Settlement of Patent Infringement Lawsuits: Antitrust Rules and Economic Implications。Fla. L. Rev.，54，747-750。 |
| 15. | Opderbeck, David W.(2010)。Rational Antitrust Policy and Reverse Payment. Settlements in Hatch- Waxman Patent Litigation。Geo. L.J.，98，1303+1320。 |
| 16. | Bieri, Diane E.(2014)。Implications of FTC v. Actavis: A Reasonable Approach to Evaluating Reverse Payment Settlements。Minnesota Journal of Law, Science & Technology，15，135-148。 |
| 17. | Cramer, Eric L.、Berger, Daniel(2014)。The Superiority of Direct Proof of Monopoly Power and Anticompetitive Effects in Antitrust Cases Involving Delayed Entry of Generic Drugs。U. S. F. L. Rev.，39，81+118。 |
| 18. | Dolin, Gregory(2011)。Reverse Settlements as Patent Invalidity Signals。Harv. J. L and Tech.，24，281+318。 |
| 19. | Butler, Henry N.、Jarosch, Jeffrey Paul(2010)。Policy Reversal on Reverse Payments: Why Courts Should Not Follow the New DOJ Position on Reverse-Payment Settlements of Pharmaceutical Patent Litigation。Iowa L. Rev，96，57+116。 |
| 20. | Hovenkamp, Herbert(2014)。Anticompetitive Patent Settlements and the Supreme Court's Actavis Decision。Minn. J. L. Sci. and Tech.，15，3+8。 |
| 21. | Markham, Jesse W. Jr.(2012)。Sailing a Sea of Doubt: A Critique of the Rule of Reason in U.S.。Fordham J. Corp. and Fin. L.，17，591-602。 |
| 22. | Postol, Linda M.(2013)。The "Rule of Reason" preferred to "Scope of Patent" Analysis When Determining Whether a Reverse Payment is Legal in the Third Circuit。Duq. Bus. L.J.，15，293+312。 |
| 23. | Lisa Allen,(2010)。Reviewing the Legality of Pharmaceutical Reverse Payment Settlements: The FTC Doesn't Get It Right。GEO. J. L. and PUB. POL’Y，8，245+247。 |
| 24. | Schildkraut, Marc G.(2004)。Patent-Splitting Settlements and the Reverse Payment Fallacy。Antitrust L.J，71，1033+1059。 |
| 25. | Kutcher, Marlee P.(2013)。Waiting is the Hardest Part: Why the Supreme Court Should Adopt the Third Circuit's Analysis of Pay-for-Delay Settlement Agreements。Loy. U. Chi. L.J.，44，1093+1135。 |
| 26. | Carrier, Michael A.(2013)。Five Arguments Laid to Rest after Actavis。ANTITRUST SRC，13(1)，1-3。 |
| 27. | Carrier, Michael A.(2009)。Solving the Drug Settlement Problem: The Legislative Approach。Rutgers L.J，41，83-84。 |
| 28. | Carrier, Michael A.(2002)。Unraveling the Patent-Antitrust Paradox。U. Pa. L. Rev.，150，761+766。 |
| 29. | Carrier, Michael A.(2009)。Unsettling Drug Patent Settlements: A Framework for Presumptive Illegality。Mich. L. Rev.，37+67。 |
| 30. | Kades, Michael(2009)。Whistling Past the Graveyard: The Problem with the Per Se Legality Treatment of Pay-For-Delay Settlements。COMPETITION Pol'y lNT'L，5，143+147。 |
| 31. | Picht, Peter(2013)。New Law on Reverse Payment Settlements-The Agenda for Courts and the Legislature After the Supreme Court's Actavis Ruling。Tul. J. Tech. and Intell. Prop.，16，105+119-122。 |
| 32. | McMillan, Richard、Bram, Mary、Tappan, Brinkley(2010)。Solving the Procedural Quagmire for Testing Reverse Payment Settlements。Minn. J. L. SCI. and Tech.，11，801+805。 |
| 33. | Backus, Scott A.(2007)。Reversing Course on Reverse Payment Settlements in the Pharmaceutical Industry: Has Schering-Plough Created the Blueprint for Defensible Antitrust Violations。OKLA. L. Rev.，60，375+379。 |
| 34. | Okada, Seiko F.(2012)。In Re K-Dur Antitrust Litigation: Pharmaceutical Reverse Payment Settlements Go Beyond the "Scope of the Patent"。N.C. J.L. and Tech.，14，303+333。 |
| 35. | Ghosh, Shubha(2014)。Convergence?。Minn. J. L. SCI. and Tech.，15，95-96。 |
| 36. | Jenkins, Stephen Roy(2004)。Valley Drug Co. v. Geneva Pharmaceuticals, Inc.: Enlarging the Patent Exclusionary Right through Hatch-Waxman Settlement Agreements Is Not Per Se Anticompetitive。Tul. J. Tech. and Intell. Prop.，295+304。 |
| 37. | Addanki, Sumanth、Butler, Henry(2014)。Activating Actavis: Economic Issues in Applying the Rule of Reason to Reverse. Payment Settlements。Minn. J. SCI. and Tech.，15，77+91。 |
| 38. | Khatibifar, Tania(2013)。The Need for a Patent-Centric Standard of Antitrust Review to Evaluate Reverse Payment Settlements。Fordham Intellectual Property, Media & Entertainment Law Journal，23，1351-1352。 |
| 39. | Cotter, Thomas F.(2014)。FTC v Actavis, Inc: When is the Rule of Reason Not the Rule of Reason?。Minn. J. L. Sci. and Tech.，15，41-44。 |
| 40. | Cotter, Thomas F.(2003)。Refining the "Presumptive Illegality" Approach to Settlements of Patent Disputes Involving Reverse Payments: A Commentary on Hovenkamp, Janis and Lemley。MlNN. L. Rev.，87，1789+1795。 |
| 41. | Cho, Tyler(2013)。Reverse Payment Settlements: The U.S. Supreme Court Has Finally Agreed to Resolve the Issue。J. Marshall Rev. Intell. Prop. L.，12，787+793。 |
| 42. | Newsom, William J.(2009)。Exceeding the Scope of the Patent: Solving the Reverse Payment Settlement Problem Through Antitrust Enforcement and Regulatory Reform。HASTINGS SCI. and Tech. L.J.，1，201+226。 |
| 43. | Onoe, Yuki(2009)。"Pay-For-Delay" Settlements in Pharmaceutical Litigation: Drawing a Fine Line Between Patent Zone and Antitrust Zone。J. MARSHALL Rev. Intell. Prop. L.，9，527+544。 |
| 44. | Shapiro, Carl(2003)。Antitrust Limits to Patent Settlements。The Rand Journal of Economics，34(2)，391-411。 |
| 45. | 陳新民(19981000)。國家的法治主義--英國的法治(The Rule of Law)與德國法治國家(Der Rechtsstaat)之概念。國立臺灣大學法學論叢，28(1)，47-121。 延伸查詢 |
其他| 1. | Majumdar, Adrian(2014)。The Role of a Consumer Harm Test in Competition Policy，http://lawecommons.luc.edu/cgi/viewcontent.cgi?article=1136&context=lclr， 2014/06/11。 |
| 2. | Sama, Danilo(2014)。The Antitrust Treatment of Loyalty Discounts and Rebates in the EU Competition Law: In Search of an Economic Approach and a Theory of Consumer Harm，http://papers.ssm.com/sol3/papers.cfm? abstract_id=2425100， 2014/07/03。 |
| 3. | FTC，U. S. Dep't of Justice(2014)。Antitrust Guidelines for Collaborations Among Competitors，http://www.ftc.gov/sites/default/files/documents/public_events/joint-venture-hearings-antitrust-uidelines-collaboration-among-competitors/ftcdojguidelines-2.pdf， 2014/07/05。 |
| 4. | Werden, Gregory J.(2014)。Antitrust's Rule of Reason: Only Competition Matters，http://papers.ssm.com/sol3/papers.cfm?abstract_id=2227097， 2014/06/22。 |
| 5. | Markham, Jesse W. Jr.(2014)。Sailing a Sea of Doubt: A Critique of the Rule of Reason in U.S. Antitrust Law，http://papers.ssm.com/sol3/papers.cfm7abstract_id=l916223， 2014/06/04。 |
| 6. | Carrier, Michael A.(2014)。The Rule of Reason: An Empirical Update for the 21st Century，http://www.georgemasonlawreview.org/doc/16-4_Carrier.pdf， 2014/06/13。 |
| 7. | Clancy, Michael J.，Geradin, Damien，Lazerow, Andrew(2014)。Reverse-Payment Patent Settlements in the Pharmaceutical Industry: An Analysis of US Antitrust Law and EU Competition Law，http://papers.ssm.com/sol3/papers.cfm?abstract_id=2345851， 2014/06/04。 |
| 8. | Gurgula, Olga(2014)。Restrictive Practices in Pharmaceutical Industry: Reverse Payment. Agreements: Seeking for a Balance between Intellectual property and Competition Law，http://www.icc.qmul.ac.uk/GAR/GAR2012/GAR%202012_2_01ga%20Gurgula.PDF， 2014/06/06。 |
| 9. | Blair, Roger D.，Sokol, D. Daniel(2014)。The Rule of Reason and the Goals of Antitrust: An Economic Approach，http://scholarship.law.ufl.edu/cgi/viewcontent.cgi?article=1302andcontext=facultypub， 2014/06/14。 |